Sintx Technologies (SINT) Cash from Operations Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 20.35% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -48.14% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.50% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 50.11% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -14.75% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.83% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | 19.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.94% |
| Dec 31, 2025 | -4.35% |
| Sep 30, 2025 | -0.52% |
| Jun 30, 2025 | 1.76% |
| Mar 31, 2025 | 25.78% |
| Dec 31, 2024 | 21.83% |
| Sep 30, 2024 | -1.65% |
| Jun 30, 2024 | 1.36% |
| Mar 31, 2024 | 2.97% |
| Dec 31, 2023 | -14.85% |
| Sep 30, 2023 | -11.41% |
| Jun 30, 2023 | -27.22% |
| Mar 31, 2023 | -12.98% |
| Dec 31, 2022 | -9.86% |
| Sep 30, 2022 | -17.03% |
| Jun 30, 2022 | -15.87% |
| Mar 31, 2022 | -23.24% |
| Dec 31, 2021 | -13.67% |
| Sep 30, 2021 | -10.53% |
| Jun 30, 2021 | 14.07% |
| Mar 31, 2021 | -9.23% |
| Dec 31, 2020 | -73.84% |
| Sep 30, 2020 | -4.02% |
| Jun 30, 2020 | 1.20% |
| Mar 31, 2020 | -22.84% |
| Dec 31, 2019 | 6.65% |
| Sep 30, 2019 | 18.71% |
| Jun 30, 2019 | -21.37% |
| Mar 31, 2019 | -5.06% |
| Dec 31, 2018 | 7.10% |
| Sep 30, 2018 | -1.32% |
| Jun 30, 2018 | -15.65% |
| Mar 31, 2018 | 8.23% |
| Dec 31, 2017 | 30.15% |
| Sep 30, 2017 | 14.66% |
| Jun 30, 2017 | 37.06% |
| Mar 31, 2017 | 2.88% |
| Dec 31, 2016 | 24.61% |
| Sep 30, 2016 | -16.42% |
| Jun 30, 2016 | 28.93% |
| Mar 31, 2016 | -9.53% |